Dehydroepiandrosterone (DHEA) Sulfate, Four Specimens
Use
The Dehydroepiandrosterone (DHEA) Sulfate test is used to assess adrenal gland function by measuring DHEA sulfate levels in the blood. This test involves collecting four specimens to evaluate changes in DHEA sulfate levels in response to a drug or other treatment. It aids in diagnosing disorders of the adrenal glands, such as adrenal hyperplasia or tumors, and provides insight into the endocrine system's response to stress or hormonal therapies.
Special Instructions
Not provided.
Limitations
The test may be affected by biotin supplementation, which can lead to inaccurate results if not ceased before specimen collection. Additionally, without proper administration of a drug or treatment after the initial sample, this panel should not be used. The test results should be interpreted in the context of other clinical findings.
Methodology
Other
Biomarkers
LOINC Codes
- 56552-3 - DHEA-S BS SerPl-mCnc
- 56552-3 - DHEA-S BS SerPl-mCnc
- 46963-5 - Tube # SerPlBld
- 16723-9 - DHEA-S sp2 p chal SerPl-mCnc
- 16724-7 - DHEA-S sp3 p chal SerPl-mCnc
- 16725-4 - DHEA-S sp4 p chal SerPl-mCnc
Result Turnaround Time
1-2 days
Related Documents
For more information, please review the documents below
Specimen
Serum
Volume
Not provided
Minimum Volume
Not provided
Collection Instructions
Refer to the Endocrine Appendix of the LabCorp Directory for instructions on multiple specimen collection. Series collection after drug or treatment administration is required.
Patient Preparation
Patients should cease biotin consumption 72 hours prior.
Causes for Rejection
Biotin interference if patient has taken biotin within 72 hours of collection.
Other tests from different labs that may be relevant